TUBLIGIN
LIVE

Serial Number

79154863

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 27, 2014

Add to watchlist:

No watchlists yet
View on USPTO

TUBLIGIN Trademark

Serial Number: 79154863 • Registration: 4737231

TUBLIGIN is a trademark filed by NOVARTIS AG on August 27, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,179 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 27, 2014

Registration Date

May 19, 2015

Published for Opposition

March 3, 2015

Cancellation Date

November 13, 2017

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; vaccines; diagnostic preparations for medical purposes

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 8, 2018 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jun 8, 2018 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 30, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 15, 2015 FICS
FINAL DISPOSITION PROCESSED
Sep 15, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 19, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
May 19, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2015 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Feb 27, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 11, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 11, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 11, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 28, 2015 PREV
ASSIGNED TO LIE
Jan 28, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 8, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 30, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 30, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 30, 2014 TROA
REFUSAL PROCESSED BY IB
Dec 19, 2014 RFNT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 17, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 17, 2014 REAP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 26, 2014 RFCS
REFUSAL PROCESSED BY MPU
Nov 26, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 25, 2014 RFCR
NON-FINAL ACTION WRITTEN
Nov 24, 2014 CNRT
ASSIGNED TO EXAMINER
Nov 21, 2014 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 18, 2014 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 14, 2014 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Nov 13, 2014 SDRC